Playback speed
10 seconds
CLL Next Generation Reversible BTK Inhibitor, For Overcoming Acquired Resistance to Irreversible BTK Inhibitors
277 views
November 5, 2018
Oral Abstract CLL 200: LOXO-305
Login to view comments.
Click here to Login